Aroda, V.R.
Ahmann, A.
Cariou, B.
Chow, F.
Davies, M.J.
Jódar, E.
Mehta, R.
Woo, V.
Lingvay, I.
This article is maintained by: Elsevier
Article Title: Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
Journal Title: Diabetes & Metabolism
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.diabet.2018.12.001
Content Type: article
Copyright: © 2018 Published by Elsevier Masson SAS.